Physician

Mark D Herron, M.D.

According to 2025 Medicare claims, Mark Herron, M.D. (NPI: 1942271812) practices dermatology in the Montgomery, AL market, with the plurality of this provider's patient population coming from Elmore, AL. This provider's primary affiliated billing organization is MARK D. HERRON, M.D. L.L.C. (NPI: 1104897073; TIN: 331114063) and primary practice location at 36117-7047.

Herron's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,412 traditional Medicare patients, billed 6,039 HCPCS/CPT codes, and received $371,618 in Medicare payments. The top billing code was 17110 (Destruction of skin growth, 1-14 growths). Part D data shows 2,735 prescription claims across 1,109 beneficiaries totaling $1,629,133 in drug costs, led by Skyrizi Pen (Risankizumab-Rzaa). Open Payments data shows 111 records totaling $2,511. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $509,009 to $1,629,133. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	1,636	6,481	$369,508
2016	1,685	6,894	$404,423
2017	1,357	5,476	$300,820
2018	1,467	5,628	$301,643
2019	1,520	5,394	$292,362
2020	1,460	5,544	$304,346
2021	1,528	5,298	$329,517
2022	1,396	5,520	$340,828
2023	1,437	5,772	$347,973
2024	1,412	6,039	$371,618

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	722	2,266	$509,009
2016	796	2,451	$972,844
2017	840	2,465	$747,285
2018	821	2,533	$542,040
2019	832	2,429	$970,433
2020	922	2,798	$1,161,524
2021	1,013	3,151	$1,142,016
2022	855	2,528	$1,965,114
2023	806	2,093	$1,544,297
2024	1,109	2,735	$1,629,133

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
17110	Destruction of skin growth, 1-14 growths	373	481	$68
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	1,006	1,627	$54
11102	Biopsy of related skin growth, first growth	514	634	$54
17000	Destruction of precancer skin growth, 1 growth	638	963	$32
17003	Destruction of precancer skin growth, 2-14 growths	251	613	$4

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Skyrizi Pen	Risankizumab-Rzaa	26	2,016	$540,564
Stelara	Ustekinumab	11	924	$143,484
Otezla	Apremilast	24	720	$116,747
Cosentyx Sensoready (2 Pens)	Secukinumab	14	392	$99,327
Rinvoq	Upadacitinib	15	450	$98,197

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	111	$2,511	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Mark D. Herron, M.D.?

Tedicare shows public-source Medicare data for Mark D. Herron, M.D. (NPI 1942271812), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Mark D. Herron, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Mark D. Herron, M.D.?

Mark D. Herron, M.D. is linked to MARK D. HERRON, M.D. L.L.C. (billing NPI 1104897073) in the available physician profile data.

Does Mark D. Herron, M.D. have Open Payments data?

Mark D. Herron, M.D. has 111 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.